Lee JJX - Search Results

1

Resected pancreatic adenocarcinoma: An Asian institution's experience.

Ng KYY, Chow EWX, Jiang B, Lim C, Goh BKP, Lee SY, Teo JY, Tan DMY, Cheow PC, Ooi LLPJ, Chow PKH, Lee JJX, Kam JH, Koh YX, Jeyaraj PR, Tan EK, Choo SP, Chan CY, Chung AYF, Tai D. Ng KYY, et al. Among authors: lee sy, lee jjx. Cancer Rep (Hoboken). 2021 Oct;4(5):e1393. doi: 10.1002/cnr2.1393. Epub 2021 May 3. Cancer Rep (Hoboken). 2021. PMID: 33939335 Free PMC article.

2

Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma.

Ng HHM, Lee RY, Goh S, Tay ISY, Lim X, Lee B, Chew V, Li H, Tan B, Lim S, Lim JCT, Au B, Loh JJH, Saraf S, Connolly JE, Loh T, Leow WQ, Lee JJX, Toh HC, Malavasi F, Lee SY, Chow P, Newell EW, Choo SP, Tai D, Yeong J, Lim TKH. Ng HHM, et al. Among authors: lee ry, lee sy, lee jjx, lee b. J Immunother Cancer. 2020 Aug;8(2):e000987. doi: 10.1136/jitc-2020-000987. J Immunother Cancer. 2020. PMID: 32847986 Free PMC article.

3

Real-world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian Center.

Ng KYY, Wong LWJ, Ang AJS, Tan SH, Choo SP, Tai DW, Lee JJX. Ng KYY, et al. Among authors: lee jjx. Asia Pac J Clin Oncol. 2021 Oct;17(5):e249-e261. doi: 10.1111/ajco.13454. Epub 2020 Sep 1. Asia Pac J Clin Oncol. 2021. PMID: 32875742

4

Myasthenia Gravis and Myocarditis After Administration of Pembrolizumab in a Patient With Metastatic Non-small Cell Lung Cancer and Resected Thymoma.

Kee W, Ng KYY, Lee JJX, Tan DSW. Kee W, et al. Among authors: lee jjx. Clin Lung Cancer. 2022 Jun;23(4):e293-e295. doi: 10.1016/j.cllc.2021.12.001. Epub 2021 Dec 10. Clin Lung Cancer. 2022. PMID: 35105525 No abstract available.

5

Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma.

Ng KYY, Tan SH, Tan JJE, Tay DSH, Lee AWX, Ang AJS, Wong LWJ, Choo SP, Tai DW, Lee JJX. Ng KYY, et al. Among authors: lee jjx. Liver Cancer. 2021 Oct 26;11(1):9-21. doi: 10.1159/000518619. eCollection 2022 Jan. Liver Cancer. 2021. PMID: 35222504 Free PMC article.

6

Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?

Ng KYY, Wong LWJ, Ang AJS, Lee AWX, Tay DSH, Tan JJE, Tan SH, Choo SP, Tai DW, Lee JJX. Ng KYY, et al. Among authors: lee jjx. Asia Pac J Clin Oncol. 2023 Jun;19(3):312-319. doi: 10.1111/ajco.13837. Epub 2022 Aug 10. Asia Pac J Clin Oncol. 2023. PMID: 35950298

7

First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-Analysis.

Fong KY, Zhao JJ, Sultana R, Lee JJX, Lee SY, Chan SL, Yau T, Tai DWM, Sundar R, Too CW. Fong KY, et al. Among authors: lee jjx. Liver Cancer. 2022 Aug 23;12(1):7-18. doi: 10.1159/000526639. eCollection 2023 Feb. Liver Cancer. 2022. PMID: 36872922 Free PMC article.

8

Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinoma.

Cheung CCL, Seah YHJ, Fang J, Orpilla NHC, Lau MC, Lim CJ, Lim X, Lee JNLW, Lim JCT, Lim S, Cheng Q, Toh HC, Choo SP, Lee SY, Lee JJX, Liu J, Lim TKH, Tai D, Yeong J. Cheung CCL, et al. Among authors: lee jjx. Front Immunol. 2023 Jun 5;14:1150985. doi: 10.3389/fimmu.2023.1150985. eCollection 2023. Front Immunol. 2023. PMID: 37342338 Free PMC article.

9

Lytic efficiency of immunosuppressive drug-resistant armoured T cells against circulating HBV-related HCC in whole blood.

Lin M, Bhakdi SC, Tan D, Lee JJX, Tai DWM, Pavesi A, Wai LE, Wang T, Bertoletti A, Tan AT. Lin M, et al. Among authors: lee jjx. Immunother Adv. 2023 Aug 14;3(1):ltad015. doi: 10.1093/immadv/ltad015. eCollection 2023. Immunother Adv. 2023. PMID: 37636242 Free PMC article.

10

Impact of Etiology on Efficacy Outcomes with Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Retrospective Analysis in Asia-Pacific.

Kim S, Lee SY, Cheon J, Kim HD, Park YG, Lee JJX, Ryu MH, Ryoo BY, Tai D, Yoo C. Kim S, et al. Among authors: lee jjx. Target Oncol. 2024 Nov;19(6):917-923. doi: 10.1007/s11523-024-01103-7. Epub 2024 Oct 3. Target Oncol. 2024. PMID: 39361219

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters